Syndax

Syndax is a Massachusetts-based biopharmaceutical company that researches and develops novel therapies for the treatment of cancer.

Business Model:

Revenue: $126.6M

Employees: 51-200

Detailed Syndax Information

Geographic Data

Syndax headquarters map

Address: 35 Gatehouse Drive

City: Waltham

State: MA

Zip: 02451

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$75M

Raised Total:

$274M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Syndax is a Massachusetts-based biopharmaceutical company that researches and develops novel therapies for the treatment of cancer.

Contact Phone:
+17814191400

Contact Email:

Syndax went public on 12/9/2020 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
12/9/2020

Ticker Symbol:
SNDX

IPO Price:
$23/share

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
4/2007 Series A 5 $40M Domain Associates
MPM Capital
Pappas Ventures
Forward Ventures
Avalon Ventures
Domain Associates
MPM Capital
2/2014 Venture Round $1.7M
8/2015 Series C $0 OrbiMed
RMI Partners
BioMed Ventures
Delos Capital
Tavistock Life Sciences
Delos Capital
Fidelity Management and Research Company
Jennison Associates
Forward Ventures
MPM Capital
EcoR1 Capital
Domain Associates
OrbiMed
RMI Partners
BioMed Ventures
Delos Capital
Tavistock Life Sciences
Delos Capital
Fidelity Management and Research Company
Jennison Associates
Forward Ventures
MPM Capital
EcoR1 Capital
Domain Associates
1/2020 Post-IPO Debt $0 Hercules Capital
AI Life Sciences Investments
Boxer Capital
Biotechnology Value Fund
Frazier Healthcare Partners
AI Life Sciences Investments
Biotechnology Value Fund
Boxer Capital
Hercules Capital
Hercules Capital
AI Life Sciences Investments
Boxer Capital
Biotechnology Value Fund
Frazier Healthcare Partners
AI Life Sciences Investments
Biotechnology Value Fund
Boxer Capital
Hercules Capital
3/2010 Series A 5 $9M Domain Associates
MPM Capital
Pappas Ventures
Forward Ventures
Avalon Ventures
Domain Associates
MPM Capital
8/2013 Series B $0 Forward Ventures
RMI Partners
MPM Capital
Domain Associates
Forward Ventures
RMI Partners
MPM Capital
Domain Associates
4/2010 Debt Financing $6M
12/2021 Post-IPO Equity $75.3M
12/2022 Post-IPO Equity $172.5M
9/2014 Debt Financing $4.9M
12/2022 Post-IPO Equity $150M
12/2020 Post-IPO Equity $143.8M
12/2021 Post-IPO Equity $86.5M
1/2016 IPO -
1/2016 IPO -
8/2015 Series C 13 $80M Delos Capital Fund LP
EcoR1 Capital
OrbiMed
Jennison Associates LLC
Tavistock Life Sciences
Arrowpoint Partners
Domain Associates
MPM Capital
RusnanoMedInvest
Forward Ventures
OrbiMed
RMI Partners
BioMed Ventures
Delos Capital
Tavistock Life Sciences
Delos Capital
Fidelity Management and Research Company
1/2020 Post-IPO Debt 5 $30M Hercules Capital
AI Life Sciences Investments
Boxer Capital
Biotechnology Value Fund
Frazier Healthcare Partners
AI Life Sciences Investments
Biotechnology Value Fund
Boxer Capital
Hercules Capital
Hercules Capital
AI Life Sciences Investments
Boxer Capital
Biotechnology Value Fund
Frazier Healthcare Partners
AI Life Sciences Investments
Biotechnology Value Fund
Boxer Capital
Hercules Capital
8/2013 Series B 4 $26.6M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research